Science Applications International (SAIC) Tests Fair Value As Momentum Builds

Science Applications International Corp.

Science Applications International Corp.

SAIC

0.00

Science Applications International (SAIC) stock was recently in focus after fresh performance data showed a 2.1% one day move, with returns of 3.0% over the week and about 9.7% for the past month.

With the share price at $118.99, Science Applications International has recently shown building momentum, with a 30 day share price return of 9.7% and a 90 day share price return of 24.45% compared with a more modest 5 year total shareholder return of 46.16%.

If you are looking for more ideas in a similar space, it could be a good time to scan the market using a focused screener for 34 robotics and automation stocks

After a strong 30 day and 90 day run, Science Applications International now sits close to its quoted analyst price target. Does the current risk reward still justify buyers paying up, or is the upside largely reflected already?

Most Popular Narrative: 1% Overvalued

The most followed narrative currently places Science Applications International's fair value at $117.80, slightly below the last close at $118.99, so the story hinges on fine margins rather than a big gap.

The analysts have a consensus price target of $117.8 for Science Applications International based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $137.0, and the most bearish reporting a price target of just $85.0.

Want to understand why a company with modest growth expectations still supports a higher projected earnings multiple and sizeable future cash flow valuation uplift? The core of this narrative lies in how stable revenues, changing margins and shrinking share count feed into that future earnings profile and discount rate. The detailed blueprint sits behind those assumptions, not in the headline fair value.

Result: Fair Value of $117.80 (OVERVALUED)

However, the Science Applications International narrative still faces pressure from tighter government budgets and rising competition, which could squeeze pricing and limit contract wins.

Another View: Multiples Point To A Different Story For Science Applications International

While the analyst narrative tags Science Applications International as about 1% overvalued on a fair value of $117.80, current trading paints a different picture. At a P/E of 12.4x versus an estimated fair ratio of 15.5x and a US Professional Services average of 22.2x, the stock screens as cheap relative to both peers and that fair ratio benchmark. This raises the question of whether the risk is paying too much today or missing a valuation gap that could close over time.

NasdaqGS:SAIC P/E Ratio as at Jul 2026
NasdaqGS:SAIC P/E Ratio as at Jul 2026

Next Steps

With Science Applications International showing mixed signals across fair value, earnings multiples and sentiment, do not wait for consensus to form before you check the underlying numbers yourself and weigh both the potential upside and the concerns highlighted in the 3 key rewards and 1 important warning sign.

Looking for more Science Applications International investment ideas?

If Science Applications International has you thinking about where to put fresh capital next, do not stop at a single stock when there are broader opportunities to review.

  • Spot potential turnaround stories early and scan through 21 elite penny stocks with strong financials that pair smaller market caps with stronger financial profiles than many expect.
  • Focus your attention on quality at a reasonable price by using the 49 high quality undervalued stocks to filter companies with solid fundamentals trading below their assessed value.
  • Prioritise resilience in choppier markets and use the 81 resilient stocks with low risk scores to concentrate on businesses flagged for lower overall risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.